Berto Acquisition Corp. (NASDAQ:TACOU) announced the pricing of its upsized $261 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TACOU”, Wednesday, April 30, 2025.
The new SPAC aims to conduct a broad search for a target but will have a particular interest in artificial intelligence, wellness, longevity, and aesthetics.
Berto’s management team is led by Executive Chairman and Interim Chief Financial Officer Harry L. You. The Board also includes Sam Lynn, Darla K. Anderson and Constance Weaver.
Total SPAC deal count for 2025 year-to-date is now 31. This offering is expected to close on Thursday, May 1, 2025.
Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, and Needham & Company, LLC are acting as joint book-running managers of the offering. White & Case LLP is serving as Issuer’s Counsel with Loeb & Loeb LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
Berto Acquisition Corp. (NASDAQ:TACOU) announced the pricing of its upsized $261 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TACOU”, Wednesday, April 30, 2025. The new SPAC aims to conduct a broad search for a target but will have a particular interest in artificial intelligence, wellness, longevity,...
Lakeshore Acquisition III Corp. (NASDAQ:LCCCU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LCCCU”, Wednesday, April 30, 2025. The new SPAC aims to conduct a broad search for a target with a team that has previously closed business combinations in the...
Churchill Capital Corp X (NASDAQ:CCCXU) has filed for a $300 million SPAC with a broad search focus, to add to the portfolio of Churchill deals. Five Churchill deals have closed (I, II, III, IV, and AltC), while V, VI and VII liquidated in the SPAC downturn. However, keep in mind that the Churchill team still...
Black Hawk Acquisition Corp (NASDAQ:BKHA) has entered into a definitive agreement to combine with biotech firm Vesicor Therapeutics at a pre-money equity value of $70 million. San Gabriel, California-based Vesicor is developing treatments utilizing extracellular vesicles as both a therapy themselves and as a delivery system for other medicines. The combined company is expected to...
At the SPAC of Dawn SPAC activity has continued to heat up as the market now has a new business combination to digest alongside two new SPACs making their debut on the Nasdaq later today. Three more new SPACs have filed their initial S-1s to eventually join them. That makes 29 SPAC IPOs and 49...